lamotrigine/sertraline (LAM/SER) / Meditop Pharma - LARVOL DELTA

[VIRTUAL] Separation Anxiety Disorder in Children Mistaken for Autism Spectrum Disorder: Psychosocial Correlates and Clinical Evidence (APA 2021) - "Only when his separation anxiety disorder was ultimately managed with lamotrigine, bupropion and sertraline [1], we were able to further proceed with psychodynamic therapy and improve his mother’s engagement in the treatment process in order to get his behavioral issues under control [2]. In this poster, we highlight the overlap in symptomatology and differences between ASD and separation anxiety disorder and demonstrate the relevance of establishing a therapeutic alliance and interacting with patients to comprehend the underlying dynamics between patients and their main attachment figures [5]. We also emphasize the extrapolation of those dynamics to patients’ interactions with others to better understand their presenting problems and clarify the differential diagnosis, which is of crucial importance due to the effectiveness of early intervention."

Clinical • ADHD (Impulsive Aggression) • Attention Deficit Hyperactivity Disorder • Autism Spectrum Disorder • Behavior Disorders • CNS Disorders • Genetic Disorders • Mood Disorders • Psychiatry

[VIRTUAL] Improvement of Superimposed Pseudo Seizures in a Patient With Anxiety Disorder (APA 2021) - "Patient was started on Lamotrigine, Sertraline and Clonazepam, with improvement of her symptoms. This case highlights the importance to be vigilant for pseudoseizures1 since misdiagnosis can often lead to inappropriate treatment, increase in readmission rates and comorbidities5."

Clinical • Bipolar Disorder • Cardiovascular • CNS Disorders • Endocrine Disorders • Epilepsy • Insomnia • Mood Disorders • Movement Disorders • Pain • Psychiatry • Sleep Disorder

[VIRTUAL] Electroconvulsive therapy for agitation in Lewy Bodies Dementia (EPA 2020) - "Medication trials including donepezil, memantine, lamotrigine, sertraline, quetiapine, risperidone and melatonine, all failed to manage his depressive, psychotic and behavorial disturbances. This case suggests that ECT has an impact in the treatment of agitation in DLB patients, although further investigation is needed."

APPLICATION OF CLIENT-CENTERED PSYCHOTHERAPY IN THE COMPLEX TREATMENT OF ADOLESCENTS WITH PSYCHOSOMATIC DISORDERS (PubMed, Georgian Med News) - "The 1-st group (57 persons) consisted of adolescents, who received treatment with Lamotrigine and Sertraline 25 mg / day for persons from 12 to 16 years old and 50 mg / day - over 16 years old. The obtained results of treatment of psychosomatic disorders in adolescents show positive influence of both methods of therapy. However, adolescents with psychosomatic disorders were most susceptible to complex treatment, which accelerates the regression of clinical manifestations and increases the effectiveness of treatment 2.85 times."

Journal

Hallucinogen persisting perception disorder: A literature review and three case reports. (PubMed, J Addict Dis) - "The first case report describes a 23-year old patient with a previous history of cannabis consumption who reported HPDD type I after the use of psilocybin mushrooms with small amounts of alcohol and hash...Both patients sought medical help and received tofisopam, lamotrigine and sertraline...Scientific sources suggest that HPPD may affect more than 50% of hallucinogen users and this disorder is often underdiagnosed. Therefore, patients suffering from HPPD can present in various clinical settings, and clinicians should be aware of this condition."

Clinical • Journal